Gujarat Themis Biosyn Limited reported earnings results for the fourth quarter and full year ended March 31, 2024. For the fourth quarter, the company reported sales was INR 420.11 million compared to INR 275.85 million a year ago. Revenue was INR 430.3 million compared to INR 295.47 million a year ago. Net income was INR 158.86 million compared to INR 116.92 million a year ago. Basic earnings per share from continuing operations was INR 2.19 compared to INR 1.61 a year ago. Diluted earnings per share from continuing operations was INR 2.19 compared to INR 1.61 a year ago.
For the full year, sales was INR 1,698.22 million compared to INR 1,483.85 million a year ago. Revenue was INR 1,741.88 million compared to INR 1,549.73 million a year ago. Net income was INR 591.63 million compared to INR 579.69 million a year ago. Basic earnings per share from continuing operations was INR 8.14 compared to INR 7.98 a year ago. Diluted earnings per share from continuing operations was INR 8.14 compared to INR 7.98 a year ago.